These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37850496)

  • 1. Infectious etiologies among post-donation deferrals in a military blood donation center.
    Kwon S; Casleton BG; Rivera GZ; Gella MM; Winkler EL; Kieffer JW; Osuna AB; Casey TM; Yun HC; Marcus JE
    Transfusion; 2023 Dec; 63(12):2265-2272. PubMed ID: 37850496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes of pre and post-donation deferrals among blood donors, at Kwale Satellite Blood Transfusion Center, Kwale County, Kenya, 2018-2022.
    Nyamu GW; Shee MA; Kiende P; Muthiani BM; Nakazea RJ; Mwasowa NM; Odhiambo F; King'oo JM; Wigina RN
    BMC Public Health; 2024 Aug; 24(1):2197. PubMed ID: 39138457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited effectiveness of donor deferral registries for transfusion-transmitted disease markers.
    Cable R; Musavi F; Notari E; Zou S;
    Transfusion; 2008 Jan; 48(1):34-42. PubMed ID: 17894796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
    CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety.
    Omidkhoda A; Razi B; Arabkhazaeli A; Amini Kafi-Abad S
    BMC Infect Dis; 2020 Oct; 20(1):736. PubMed ID: 33028232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sero-epidemiology of human immunodeficiency virus, hepatitis B and C viruses, and syphilis infections among first-time blood donors in Edéa, Cameroon.
    Noubiap JJ; Joko WY; Nansseu JR; Tene UG; Siaka C
    Int J Infect Dis; 2013 Oct; 17(10):e832-7. PubMed ID: 23317526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seroprevalence of hepatitis B, hepatitis C, human immunodeficiency virus, Treponema pallidum, and co-infections among blood donors in Kyrgyzstan: a retrospective analysis (2013-2015).
    Karabaev BB; Beisheeva NJ; Satybaldieva AB; Ismailova AD; Pessler F; Akmatov MK
    Infect Dis Poverty; 2017 Feb; 6(1):45. PubMed ID: 28222792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Seroprevalence of transfusion-transmissible infections and evaluation of the pre-donation screening performance at the Provincial Hospital of Tete, Mozambique.
    Stokx J; Gillet P; De Weggheleire A; Casas EC; Maendaenda R; Beulane AJ; Jani IV; Kidane S; Mosse CD; Jacobs J; Bottieau E
    BMC Infect Dis; 2011 May; 11():141. PubMed ID: 21605363
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seroprevalence and diagnosis of HIV, HBV, HCV and syphilis infections among blood donors.
    Tafesse TB; Gebru AA; Gobalee S; Belay GD; Belew MT; Ataro D; Ebrahim BA; Shebeshi GM; Yimam Y
    Hum Antibodies; 2017; 25(1-2):39-55. PubMed ID: 28009328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroprevalence of transfusion transmitted infection among blood donors at Jijiga blood bank, Eastern Ethiopia: retrospective 4 years study.
    Mohammed Y; Bekele A
    BMC Res Notes; 2016 Feb; 9():129. PubMed ID: 26922241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Seroprevalence of viral markers among blood donors at the Blood Donor Center of Mohammed V Military Teaching Hospital of Rabat, Morocco].
    Uwingabiye J; Zahid H; Unyendje L; Hadef R
    Pan Afr Med J; 2016; 25():185. PubMed ID: 28292147
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus in United States blood donations, 2015 to 2019: The Transfusion-Transmissible Infections Monitoring System (TTIMS).
    Steele WR; Dodd RY; Notari EP; Xu M; Nelson D; Kessler DA; Reik R; Williams AE; Custer B; Stramer SL;
    Transfusion; 2020 Oct; 60(10):2327-2339. PubMed ID: 32869326
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood donors' positivity for transfusion-transmissible infections: the Serbian Military Medical Academy experience.
    Vučetić D; Kecman G; Ilić V; Balint B
    Blood Transfus; 2015 Oct; 13(4):569-75. PubMed ID: 26057495
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of HBV, HCV, HIV-1, 2 and HTLV-I/II infections among blood donors in a teaching hospital in the Central region of Saudi Arabia.
    El-Hazmi MM
    Saudi Med J; 2004 Jan; 25(1):26-33. PubMed ID: 14758374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of nucleic acid testing to detect human immunodeficiency virus, hepatitis C virus, and hepatitis B virus yields from a single blood center in China with 10-years review.
    Wu D; Feng F; Wang X; Wang D; Hu Y; Yu Y; Huang J; Wang M; Dong J; Wu Y; Zhu H; Zhu F
    BMC Infect Dis; 2022 Mar; 22(1):279. PubMed ID: 35321684
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis B virus, hepatitis C virus, human immunodeficiency virus and Treponema pallidum infections in hospitalized patients before transfusion in Xiangya hospital Central South University, China from 2011 to 2016.
    Cao WW; Zhou RR; Ou X; Shi LX; Xiao CQ; Chen TY; Tan H; Fan XG; Li BJ; Li N
    BMC Infect Dis; 2018 Apr; 18(1):145. PubMed ID: 29606088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends of blood-borne infectious diseases in a rural blood donation center of southeast Gabon (Koula-Moutou).
    Bisseye C; Mombo LE; Bie SMM; Edou A; Eko-Mba JM; Etho-Mengue JC; Mbacky K; Mongo-Delis A; M'batchi B; Nagalo BM
    Pan Afr Med J; 2018; 31():81. PubMed ID: 31007828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The risk of transmitting HCV, HBV or HIV by blood transfusion in Victoria.
    Whyte GS; Savoia HF
    Med J Aust; 1997 Jun; 166(11):584-6. PubMed ID: 9201178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of transfusion-transmissible infections (HBV, HCV, syphilis and HIV) among prospective blood donors in a tertiary health care facility in Calabar, Nigeria; an eleven years evaluation.
    Okoroiwu HU; Okafor IM; Asemota EA; Okpokam DC
    BMC Public Health; 2018 May; 18(1):645. PubMed ID: 29788937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seroprevalence of human immunodeficiency virus, hepatitis B and C viruses and syphilis among blood donors in Koudougou (Burkina Faso) in 2009.
    Nagalo MB; Sanou M; Bisseye C; Kaboré MI; Nebie YK; Kienou K; Kiba A; Dahourou H; Ouattara S; Zongo JD; Simporé J
    Blood Transfus; 2011 Oct; 9(4):419-24. PubMed ID: 21839011
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.